Generic Name and Formulations:
Acarbose 25mg, 50mg, 100mg; tabs.
Indications for PRECOSE:
Adjunct to diet in type 2 diabetes, alone or with insulin, metformin, or a sulfonylurea.
Take with first bite of each main meal. Initially 25mg three times daily; increase at 4–8 wk intervals if needed. Or, (to minimize GI effects): initially 25mg once daily, increase gradually to 25mg three times daily. Range: 50–100mg three times daily. ≤60kg: max 50mg three times daily; >60kg: max 100mg three times daily.
Ketoacidosis. Cirrhosis. Inflammatory bowel disease. Colonic ulceration. Partial or predisposition to intestinal obstruction. Chronic intestinal disease with marked disorders of digestion or absorption. Conditions that may deteriorate from increased intestinal gas formation.
Significant renal dysfunction (serum creatinine >2mg/dL): not recommended. Use glucose, not sucrose, to treat hypoglycemia. Stress. Monitor 1-hour postprandial glucose initially and during titration, then glycosylated hemoglobin. Monitor serum transaminases every 3 months during 1st year and periodically thereafter. Pregnancy (Cat.B): consider insulin instead. Nursing mothers: not recommended.
Caution with drugs that cause hyperglycemia (eg, diuretics, steroids, estrogens, phenothiazines, thyroid products, phenytoin, niacin, sympathomimetics, calcium channel blockers, isoniazid). Antagonized by intestinal adsorbents (eg, charcoal), pancreatin, amylase, other carbohydrate-splitting enzymes. Monitor digoxin; and for hypoglycemia if used with insulin or a sulfonylurea. May result in unreliable measurements of 1,5-AG assay; use alternative methods to monitor glycemic control.
Transient flatulence, diarrhea, abdominal pain.
Sign Up for Free e-newsletters
- Choice of Breast Reconstruction After Mastectomy Affects Satisfaction, Quality of Life
- Bariatric Surgery Reduced Risk of Some Cancers in Obese Patients
- Carfilzomib Benefits May Outweigh Cardiovascular Risk in Multiple Myeloma
- The Caregivers' Cancer Journey
- Genetic Link Between Depression and Breast Cancer Remains Unclear
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
- Fertility Preservation in Hodgkin's Lymphoma Patients That Undergo Targeted Molecular Therapies: An Important Step Forward From the Chemotherapy Era
- Survey of ACEP Councilors Reveals NP, PA Staffing Models, Practice Patterns Vary
- Breath Analysis May Be an Effective Diagnostic for Pancreatic Cancer
- Genetic Susceptibility to Pancreatic Cancer Linked to 6 Specific Gene Mutations
- Dinner Hour and Sleep Habits Affect Risk of Breast, Prostate Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|